Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2021

01-03-2021 | Pancreatoduodenostomy | ASO Author Reflections

ASO Author Reflections: Optimal Procedure of Surgical Resection for Pancreatic Body Cancer under Consideration of Significance of Peripancreatic Head Lymph Node Dissection

Authors: Taisuke Imamura, MD, PhD, Yusuke Yamamoto, MD, PhD, Teiichi Sugiura, MD, PhD, Yukiyasu Okamura, MD, PhD, Takaaki Ito, MD, PhD, Ryo Ashida, MD, PhD, Katsuhisa Ohgi, MD, Katsuhiko Uesaka, MD, PhD

Published in: Annals of Surgical Oncology | Issue 3/2021

Login to get access

Excerpt

Pancreatic cancer is known to invade adjacent organs and the nerve plexus around major vessels, and it has a high incidence of lymph node metastasis. Therefore, radical extended resection, including extended lymphadenectomy and dissection of the nerve plexus around major vessels, was emphasized to enhance resectability and survival. However, several randomized controlled studies13 have demonstrated that extended pancreatectomy does not have survival benefit. The National Comprehensive Cancer Network (NCCN) guidelines mention that the goals of surgery for adenocarcinoma of the pancreas include oncologic resection of the primary tumor and regional lymph nodes. However, a consensus regarding the optimal extent of lymph node dissection has not yet been achieved. Especially for pancreatic body (Pb) cancer, whether a pancreatoduodenectomy (PD) or distal pancreatectomy (DP) is the optimal procedure remains unclear from the viewpoint of appropriate lymph node dissection. …
Literature
1.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–66; discussion 366–358.CrossRef Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–66; discussion 366–358.CrossRef
2.
go back to reference Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138(4):618–28; discussion 628–630.CrossRef Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138(4):618–28; discussion 628–630.CrossRef
3.
go back to reference Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg. 2014;259(4):656–64.CrossRef Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg. 2014;259(4):656–64.CrossRef
5.
go back to reference Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82(3):346–51.CrossRef Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82(3):346–51.CrossRef
Metadata
Title
ASO Author Reflections: Optimal Procedure of Surgical Resection for Pancreatic Body Cancer under Consideration of Significance of Peripancreatic Head Lymph Node Dissection
Authors
Taisuke Imamura, MD, PhD
Yusuke Yamamoto, MD, PhD
Teiichi Sugiura, MD, PhD
Yukiyasu Okamura, MD, PhD
Takaaki Ito, MD, PhD
Ryo Ashida, MD, PhD
Katsuhisa Ohgi, MD
Katsuhiko Uesaka, MD, PhD
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09084-3

Other articles of this Issue 3/2021

Annals of Surgical Oncology 3/2021 Go to the issue